Chandra Asri Pacific Past Earnings Performance
Past criteria checks 0/6
Chandra Asri Pacific's earnings have been declining at an average annual rate of -37.1%, while the Chemicals industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 2.4% per year.
Key information
-37.1%
Earnings growth rate
-36.0%
EPS growth rate
| Chemicals Industry Growth | 12.4% |
| Revenue growth rate | 2.4% |
| Return on equity | -2.4% |
| Net Margin | -4.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Chandra Asri Pacific makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,729 | -72 | 93 | 0 |
| 30 Jun 24 | 1,952 | -80 | 107 | 0 |
| 31 Mar 24 | 2,130 | -75 | 111 | 0 |
| 31 Dec 23 | 2,160 | -34 | 110 | 0 |
| 30 Sep 23 | 2,099 | -59 | 119 | 0 |
| 30 Jun 23 | 2,122 | -86 | 103 | 0 |
| 31 Mar 23 | 2,209 | -130 | 106 | 0 |
| 31 Dec 22 | 2,385 | -150 | 105 | 0 |
| 30 Sep 22 | 2,647 | -126 | 101 | 0 |
| 30 Jun 22 | 2,655 | -78 | 104 | 0 |
| 31 Mar 22 | 2,660 | 56 | 94 | 0 |
| 31 Dec 21 | 2,580 | 152 | 91 | 0 |
| 30 Sep 21 | 2,420 | 238 | 96 | 0 |
| 30 Jun 21 | 2,229 | 257 | 94 | 0 |
| 31 Mar 21 | 1,928 | 154 | 90 | 0 |
| 31 Dec 20 | 1,806 | 51 | 84 | 0 |
| 30 Sep 20 | 1,761 | -28 | 74 | 0 |
| 30 Jun 20 | 1,667 | -50 | 80 | 0 |
| 31 Mar 20 | 1,806 | -12 | 82 | 0 |
| 31 Dec 19 | 1,881 | 23 | 85 | 0 |
| 30 Sep 19 | 1,969 | 43 | 81 | 0 |
| 30 Jun 19 | 2,311 | 99 | 73 | 0 |
| 31 Mar 19 | 2,400 | 126 | 72 | 0 |
| 31 Dec 18 | 2,543 | 182 | 76 | 0 |
| 30 Sep 18 | 2,583 | 238 | 80 | 0 |
| 30 Jun 18 | 2,509 | 260 | 80 | 0 |
| 31 Mar 18 | 2,481 | 284 | 80 | 0 |
| 31 Dec 17 | 2,419 | 319 | 81 | 0 |
| 30 Sep 17 | 2,330 | 334 | 79 | 0 |
| 30 Jun 17 | 2,244 | 342 | 77 | 0 |
| 31 Mar 17 | 2,205 | 369 | 80 | 0 |
| 31 Dec 16 | 1,930 | 300 | 71 | 0 |
| 30 Sep 16 | 1,632 | 212 | 69 | 0 |
| 30 Jun 16 | 1,460 | 140 | 62 | 0 |
| 31 Mar 16 | 1,378 | 62 | 66 | 0 |
| 31 Dec 15 | 1,378 | 26 | 67 | 0 |
| 30 Sep 15 | 1,658 | 36 | 68 | 0 |
| 30 Jun 15 | 1,962 | 30 | 75 | 0 |
| 31 Mar 15 | 2,176 | 20 | 67 | 0 |
| 31 Dec 14 | 2,460 | 18 | 67 | 0 |
| 30 Sep 14 | 2,640 | 29 | 67 | 0 |
| 30 Jun 14 | 2,586 | 12 | 69 | 0 |
| 31 Mar 14 | 2,559 | 14 | 67 | 0 |
| 31 Dec 13 | 2,506 | 10 | 67 | 0 |
Quality Earnings: 878 is currently unprofitable.
Growing Profit Margin: 878 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 878 is unprofitable, and losses have increased over the past 5 years at a rate of 37.1% per year.
Accelerating Growth: Unable to compare 878's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 878 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (7.2%).
Return on Equity
High ROE: 878 has a negative Return on Equity (-2.42%), as it is currently unprofitable.